UniSa - IRIS Institutional Research Information System

SELLERI, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.546
AS - Asia 22.539
EU - Europa 10.239
SA - Sud America 1.526
AF - Africa 254
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 24
Totale 58.159
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.207
HK - Hong Kong 13.317
SG - Singapore 4.256
FI - Finlandia 4.165
CN - Cina 2.079
VN - Vietnam 1.267
IT - Italia 1.223
UA - Ucraina 1.205
BR - Brasile 1.133
DE - Germania 1.070
RU - Federazione Russa 761
IE - Irlanda 441
FR - Francia 395
KR - Corea 340
TR - Turchia 307
IN - India 274
GB - Regno Unito 217
SE - Svezia 194
ES - Italia 182
CA - Canada 164
AR - Argentina 162
BD - Bangladesh 147
AT - Austria 108
JP - Giappone 104
MX - Messico 93
IQ - Iraq 76
ZA - Sudafrica 75
NL - Olanda 63
PL - Polonia 58
PK - Pakistan 57
EC - Ecuador 55
ID - Indonesia 47
VE - Venezuela 44
CZ - Repubblica Ceca 43
CO - Colombia 41
MA - Marocco 37
UZ - Uzbekistan 34
SA - Arabia Saudita 31
CL - Cile 30
MY - Malesia 30
ET - Etiopia 28
EU - Europa 28
PY - Paraguay 25
JO - Giordania 24
EG - Egitto 23
PH - Filippine 21
KE - Kenya 20
AE - Emirati Arabi Uniti 19
LT - Lituania 19
TN - Tunisia 18
AU - Australia 17
PE - Perù 16
DO - Repubblica Dominicana 15
DZ - Algeria 14
HN - Honduras 14
KG - Kirghizistan 14
KZ - Kazakistan 12
CH - Svizzera 11
UY - Uruguay 10
CR - Costa Rica 9
PA - Panama 9
AL - Albania 8
BE - Belgio 8
OM - Oman 8
AZ - Azerbaigian 7
IL - Israele 7
AO - Angola 6
BO - Bolivia 6
LB - Libano 6
LV - Lettonia 6
MD - Moldavia 6
NG - Nigeria 6
NP - Nepal 6
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
TH - Thailandia 6
GT - Guatemala 5
HR - Croazia 5
HU - Ungheria 5
JM - Giamaica 5
NI - Nicaragua 5
PS - Palestinian Territory 5
RS - Serbia 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BG - Bulgaria 4
BZ - Belize 4
GR - Grecia 4
KW - Kuwait 4
LU - Lussemburgo 4
LY - Libia 4
MK - Macedonia 4
QA - Qatar 4
RO - Romania 4
AM - Armenia 3
BH - Bahrain 3
CI - Costa d'Avorio 3
IR - Iran 3
NO - Norvegia 3
Totale 58.095
Salva come PNG Salva come JPEG
Città #
Hong Kong 13.283
Ann Arbor 4.703
Helsinki 3.835
Woodbridge 2.446
Singapore 2.154
San Jose 1.890
Jacksonville 1.462
Chandler 1.347
Houston 1.191
Princeton 1.164
Dallas 1.141
Wilmington 1.111
Ashburn 1.108
Munich 451
Council Bluffs 440
Dong Ket 422
Dublin 419
Beijing 387
Lauterbourg 345
Ho Chi Minh City 293
The Dalles 284
Andover 283
Nanjing 261
Izmir 248
Boardman 245
Los Angeles 229
Moscow 219
Salerno 213
Hanoi 194
New York 183
Pellezzano 171
Düsseldorf 145
Naples 141
Santa Clara 131
São Paulo 121
Valencia 120
Fairfield 100
Nuremberg 95
Shenyang 90
Orem 88
Changsha 86
Nanchang 86
Jiaxing 81
Tokyo 79
Hebei 77
Brooklyn 69
Frankfurt am Main 69
Chennai 66
Turku 62
Buffalo 58
Rome 58
Washington 57
Chicago 55
Redwood City 55
Montreal 54
Warsaw 54
London 50
Tianjin 49
Norwalk 48
Johannesburg 46
Vienna 45
Manchester 42
Pune 42
Seattle 42
Rio de Janeiro 41
Amsterdam 39
Dearborn 37
Phoenix 37
Brno 36
Da Nang 36
Denver 36
Napoli 36
Milan 35
Atlanta 34
Boston 34
Cambridge 34
Haiphong 34
San Francisco 34
Columbus 33
Toronto 33
Stockholm 32
Tashkent 32
Brasília 31
Mumbai 31
Memphis 29
Mexico City 29
Addis Ababa 28
Baghdad 28
Belo Horizonte 27
San Diego 27
Shanghai 26
Guangzhou 25
Jinan 23
Lahore 23
Dhaka 22
Amman 21
Charlotte 21
Curitiba 21
Mestre 20
Quito 20
Totale 45.668
Salva come PNG Salva come JPEG
Nome #
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 2.032
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 1.983
The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. 907
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 892
Computer aided identification of small molecules interfering with the functional interaction of the urokinase receptor with fMLP receptors 861
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 712
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 655
Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. 590
Endocrine disorders during the first year after autologous stem-cell transplant. 590
Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples 581
Chondrogenic Commitment of human Bone Marrow Mesenchymal Stem Cells in a perfused, hTGF-β1-releasing PLGA microcarrier seeded, collagen hydrogel 571
2-deoxy-2-(18F)fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis 515
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 494
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 486
Aplastic anemia: Pathophysiology 485
67 KDA laminin receptor expression in human G-CSF mobilized CD34(+) peripheral blood stem cells correlates with their mobilization efficiency 473
Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia 473
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 418
Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review 373
Expression and function of the 67kDa laminin receptor in normal and acute leukemia cells 372
Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. 369
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 360
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 356
Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes 340
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 329
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis 326
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 324
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 315
High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies 309
All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia 288
A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes 288
Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment 278
Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells 274
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 247
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts 225
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 217
The urokinase-receptor in infectious diseases. 211
The cleaved form of soluble urokinase-receptor stimulates migration and mobilization of mouse CD34(+) cells in vitro and in vivo 205
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 202
CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples 200
Soluble forms of UPAR regulate adhesion, proliferation and survival of KG1 leukemic cells 198
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 198
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 197
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 194
A backwards evolution in a case of myeloproliferative disease 193
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 192
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 192
Interleukin-2 therapy in relapsed acute myelogenous leukemia. 189
Function and malfunction of hematopoietic stem cells in primary bone marrow failure syndromes. 182
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 180
67 kDa laminin receptor: structure, function and role in cancer and infection. 178
Bendamustine in combination with rituximab as first line therapy for patients with chronic lymphocytic leukemia (cll): a retrospective real practice italian multicentre study. 177
Unresponsiveness to erythropoietin therapy in a case of Blackfan Diamond anemia. 176
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 176
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial 176
Adjuvant treatment of diabetic foot 174
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 174
A candidate complement inhibitor for the treatment of paroxysmal nocturnal haemoglobinuria (PNH): preclinical data with tt30, a therapeutic that selectively blocks the complement alternative pathway. 173
Continuous alternate-day low dose lenalidomide in combination with low dose prednisone as frontline treatment for octogenarian newly diagnosed multiple myeloma patients 172
Bendamustine in combination with rituximab for elderly patients with aggressive B non hodgkin lymphoma not eligible for anthracycline-based therapy 171
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 168
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 167
Circulating T Regulatory Cells Are Persistently Reduced in Non-Severe Acquired Aplastic Anemia 165
Role of the urokinase receptor in hematopoietic stem cell transplantation 165
A GITMO randomised trial in steroid refractory acute graft-versus-host disease: 6methylprednisolone with or without anti-thymocyte globulin 162
A randomized trial of bone marrow (BM) versus peripheral blood (PB) allogeneic hemopoietic stem cell transplants (HSCT) in patients with myeloproliferative disorders. 161
A novel chromosomal abnormality detected in a case of acute myelomonocytic leukemia. 160
EFFICACY OF ALEMTUZUMAB PLUS EXTRACORPOREAL PHOTOPHERESIS IN ADVANCED STAGE SEZARY SYNDROME: A CASE REPORT 160
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 160
Expression of the 67 kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation 159
Higher expression of Fas receptor on CD34+ cells of chronic myelogenous leukemia correlates with hematological response to IFN-alfa. 159
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 158
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 156
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 154
67 KDa laminin receptor (67LR) expression and function in normal and acute myeloid leukemia CD34(+) cells 153
High frequency of extramedullary relapse in patients transplanted for acute myeloid leukemia. 153
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 153
High dose rHuEPO may induce complete remission in AML-M6 152
The role of FAS-mediated apoptosis in chronic myelogenous leukemia. 151
Discovery of new small molecules targeting the vitronectin binding site of the urokinase receptor that block normal and leukemic cell migration 149
Blockade of intravascular hemolysis in PNH with the terminal complement inhibitor eculizumab unmasks low-level hemolysis potentially occurring through C3 opsonization 148
Increased expression of the signaling lymphocyte-activation molecule (mSLAM) in patients with paroxysmal nocturnal hemoglobinuria (PNH). 148
Fas-mediated downmodulation of p210 BCR/ABL results in apoptosis of CD34+ cells of chronic myelogenous leukemia. 146
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations 146
Impact of cytokine gene polymorphisms in myelodysplastic syndromes (MDS) 145
Fluorescent in situ hybridization with a Y probe in the follow up of sex-mismatch transplanted patients 145
Impact of cytokine gene polymorphism in aplastic anemia (AA) 145
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion 145
Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GVHD: preliminary observations. 144
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 144
Two year follow-up of cyclosporin-A in hypoplastic myelodysplastic leukemia. 144
Involvement of the urokinase receptor in the cross-talk between hematopoietic stem/progenitor cells and the bone marrow microenvironment. 144
Allogeneic transplantation for multiple myeloma 143
Effects of leptin and IGF-1 on bone mineral density in long-term survivors after allogeneic stem cell transplantation for hematological malignancies 142
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 142
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 142
Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients. 141
A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. 140
miRNA-MEDIATED CO-REGULATION OF UROKINASE RECEPTOR AND CXCR4 EXPRESSION 140
Electrophysiological Studies in Combination With Interim-Positron Emission Tomography Scan for Prevention of Severe Brentuximab-Vedotin-Induced Neurotoxicity 139
Totale 29.826
Salva come PNG Salva come JPEG
Categoria #
all - tutte 160.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021473 0 0 0 0 0 0 0 0 0 0 0 473
2021/20222.072 21 9 15 65 58 61 21 74 309 273 267 899
2022/20233.454 333 179 103 358 477 728 52 354 560 22 176 112
2023/20241.769 182 250 131 101 144 264 75 93 16 68 105 340
2024/20254.744 165 77 63 149 223 610 880 501 672 253 500 651
2025/202631.185 2.517 6.957 6.325 1.229 1.973 1.104 3.078 579 4.776 1.791 393 463
Totale 58.865